leisure time -WSS

leisure time

author：Wikipedia 2025-09-06 03:25:58 - browse：3457

Illustration of a hospital being handed from a doctor to a business person – politics and policy coverage from STAT — New guidelines from federal antitrust enforcers would have big implications on health care deals. Adobe

Health care companies trying to merge can expect tougher policing from the top federal antitrust agencies, according to a set of new draft guidelines released Wednesday.

The Department of Justice and Federal Trade Commission laid out 13 proposed guidelines detailing how they will judge whether proposed mergers and acquisitions are anticompetitive and should be challenged.

The rules would apply broadly across the economy, but they have strong implications for the health care industry, where sizable deals among hospitals, physician practices, private equity firms, health insurers, pharmacy benefit managers, pharmaceutical companies, medical device firms, and numerous other entities occur almost weekly. Research has shown that health care’s highly concentrated markets are a major reason why prices and spending have soared for patients and taxpayers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Future doctors need a strong humanities education

WSS

FDA endorses new sterilization method for medical devices

Medicare drug price lawsuits could be good politics for Biden

High breast density mammograms need follow

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

3 medical device trends to watch in 2024

White House finalizes ITC's import ban of latest Apple Watches

focus

leisure time

focus

Dobbs anniversary: the lost opportunity of abortion as health care

What causes osteoarthritis? Researchers study link to brain protein

Medicare details structure of new drug price negotiation program

FDA sets aggressive timeline for overhauling inspection procedures

Psychedelics group wrestles with new pharma identity

Ahead of JPM, here's who's profiting most in health care

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Heart attack and stroke risk calculators need revising

What causes osteoarthritis? Researchers study link to brain protein

hotspot

UCB departs biotech trade group BIO

3 trends to watch in health tech's hiring outlook for 2024

Medicare bonuses could stop drug shortages under Senate plan

AdventHealth escalates lawsuit against insurance vendor Multiplan

Antibiotic resistance and the global rise in human conflict

Federal weight loss drug coverage is 30 years out of date

knowledge

explore

knowledge

hotspot